UK markets open in 7 hours 32 minutes

OncoCyte Corporation (OCX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.7600-0.1700 (-5.80%)
At close: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
9,432
19,993
32,948
7,143
Other short-term investments
0
433
904
675
Total cash
9,432
20,426
33,852
7,818
Net receivables
484
2,012
1,437
203
Inventory
-
-
304
0
Other current assets
643
977
901
295
Total current assets
10,698
25,536
39,143
9,226
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
5,436
10,851
8,369
7,964
Accumulated depreciation
-
-
-2,715
-1,440
Net property, plant and equipment
5,436
10,851
8,369
6,524
Equity and other investments
-
-
0
13,417
Goodwill
-
0
18,684
9,187
Intangible assets
56,595
61,633
61,721
15,009
Other long-term assets
2,163
2,071
31,646
2,056
Total non-current assets
64,194
74,555
120,420
46,193
Total assets
74,892
100,091
159,563
55,419
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
1,313
2,390
Accounts payable
953
1,253
1,810
432
Accrued liabilities
1,568
3,948
3,473
2,284
Other current liabilities
45
2,005
1,526
600
Total current liabilities
7,194
12,106
14,120
8,996
Non-current liabilities
Long-term debt
-
-
-
1,508
Other long-term liabilities
39,900
45,662
76,681
7,120
Total non-current liabilities
47,230
53,693
80,226
12,940
Total liabilities
54,424
65,799
94,346
21,936
Stockholders' equity
Common stock
310,295
294,929
252,954
157,160
Retained earnings
-289,876
-260,676
-187,774
-123,677
Accumulated other comprehensive income
49
39
37
0
Total stockholders' equity
20,468
34,292
65,217
33,483
Total liabilities and stockholders' equity
74,892
100,091
159,563
55,419